Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism
Bioconjugation of a recently developed photoacoustic nanoprobe, based on silica-templated eumelanin-silver hybrid nanoparticles (MelaSil_Ag-NPs), with human serum albumin (HSA) is disclosed herein as an efficient and practical strategy to improve photostability and to perform SPARC mediated internal...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360861/ https://www.ncbi.nlm.nih.gov/pubmed/32733871 http://dx.doi.org/10.3389/fbioe.2020.00765 |
_version_ | 1783559297823670272 |
---|---|
author | Sanità, Gennaro Armanetti, Paolo Silvestri, Brigida Carrese, Barbara Calì, Gaetano Pota, Giulio Pezzella, Alessandro d’Ischia, Marco Luciani, Giuseppina Menichetti, Luca Lamberti, Annalisa |
author_facet | Sanità, Gennaro Armanetti, Paolo Silvestri, Brigida Carrese, Barbara Calì, Gaetano Pota, Giulio Pezzella, Alessandro d’Ischia, Marco Luciani, Giuseppina Menichetti, Luca Lamberti, Annalisa |
author_sort | Sanità, Gennaro |
collection | PubMed |
description | Bioconjugation of a recently developed photoacoustic nanoprobe, based on silica-templated eumelanin-silver hybrid nanoparticles (MelaSil_Ag-NPs), with human serum albumin (HSA) is disclosed herein as an efficient and practical strategy to improve photostability and to perform SPARC mediated internalization in breast cancer cells. Modification of NPs with HSA induced a slight viability decrease in breast cancer cells (HS578T) and normal breast cells (MCF10a) when incubated with HSA-NPs up to 100 μg/mL concentration for 72 h and a complete suppression of hemotoxicity for long incubation times. Uptake experiments with MelaSil_Ag-HSA NPs indicated very high and selective internalization via SPARC in HS578T (SPARC positive cells) but not in MCF10a (SPARC negative cells), as evaluated by using endocytosis inhibitors. The binding of SPARC to HSA was confirmed by Co-IP and Dot-blot assays. Additional studies were performed to analyze the interaction of MelaSil_Ag-HSA NPs with protein corona. Data showed a dramatic diminution of interacting proteins in HSA conjugated NPs compared to bare NPs. HSA-coated MelaSil_Ag-NPs are thus disclosed as a novel functional nanohybrid for potential photoacoustic imaging applications. |
format | Online Article Text |
id | pubmed-7360861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73608612020-07-29 Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism Sanità, Gennaro Armanetti, Paolo Silvestri, Brigida Carrese, Barbara Calì, Gaetano Pota, Giulio Pezzella, Alessandro d’Ischia, Marco Luciani, Giuseppina Menichetti, Luca Lamberti, Annalisa Front Bioeng Biotechnol Bioengineering and Biotechnology Bioconjugation of a recently developed photoacoustic nanoprobe, based on silica-templated eumelanin-silver hybrid nanoparticles (MelaSil_Ag-NPs), with human serum albumin (HSA) is disclosed herein as an efficient and practical strategy to improve photostability and to perform SPARC mediated internalization in breast cancer cells. Modification of NPs with HSA induced a slight viability decrease in breast cancer cells (HS578T) and normal breast cells (MCF10a) when incubated with HSA-NPs up to 100 μg/mL concentration for 72 h and a complete suppression of hemotoxicity for long incubation times. Uptake experiments with MelaSil_Ag-HSA NPs indicated very high and selective internalization via SPARC in HS578T (SPARC positive cells) but not in MCF10a (SPARC negative cells), as evaluated by using endocytosis inhibitors. The binding of SPARC to HSA was confirmed by Co-IP and Dot-blot assays. Additional studies were performed to analyze the interaction of MelaSil_Ag-HSA NPs with protein corona. Data showed a dramatic diminution of interacting proteins in HSA conjugated NPs compared to bare NPs. HSA-coated MelaSil_Ag-NPs are thus disclosed as a novel functional nanohybrid for potential photoacoustic imaging applications. Frontiers Media S.A. 2020-07-08 /pmc/articles/PMC7360861/ /pubmed/32733871 http://dx.doi.org/10.3389/fbioe.2020.00765 Text en Copyright © 2020 Sanità, Armanetti, Silvestri, Carrese, Calì, Pota, Pezzella, d’Ischia, Luciani, Menichetti and Lamberti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Sanità, Gennaro Armanetti, Paolo Silvestri, Brigida Carrese, Barbara Calì, Gaetano Pota, Giulio Pezzella, Alessandro d’Ischia, Marco Luciani, Giuseppina Menichetti, Luca Lamberti, Annalisa Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title | Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title_full | Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title_fullStr | Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title_full_unstemmed | Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title_short | Albumin-Modified Melanin-Silica Hybrid Nanoparticles Target Breast Cancer Cells via a SPARC-Dependent Mechanism |
title_sort | albumin-modified melanin-silica hybrid nanoparticles target breast cancer cells via a sparc-dependent mechanism |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360861/ https://www.ncbi.nlm.nih.gov/pubmed/32733871 http://dx.doi.org/10.3389/fbioe.2020.00765 |
work_keys_str_mv | AT sanitagennaro albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT armanettipaolo albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT silvestribrigida albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT carresebarbara albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT caligaetano albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT potagiulio albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT pezzellaalessandro albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT dischiamarco albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT lucianigiuseppina albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT menichettiluca albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism AT lambertiannalisa albuminmodifiedmelaninsilicahybridnanoparticlestargetbreastcancercellsviaasparcdependentmechanism |